Practical importance of neuroprotection in Parkinson's disease
✍ Scribed by P. Riederer; G. Gille; T. Müller; H. Przuntek; H. Reichmann; O. Riess; A. Schwartz; J. Schwarz; T. Vogt
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 163 KB
- Volume
- 249
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr
In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th